Dermata Therapeutics, Inc. (DRMA) shareholders
Close on Nov 17, 2026Market cap $2.29MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Armistice Capital, LLC Joint filing with Steven Boyd (9.99%) | 1,065,076 | 9.99% | 13G (passive) amendment | Mar 31, 2025 |
| Proehl Gerald T | 694,687 | 17.30% | 13D (active) amendment | Feb 19, 2026 |
| Bigger Michael | 414,064 | 8.36% | 13G (passive) | Sep 30, 2026 |
| Kyri K. Van Hoose | 384,352 | 9.00% | 13D (active) | May 27, 2026 |
| Intracoastal Capital LLC Joint filing with Mitchell P. Kopin (5.50%), Daniel B. Asher (5.50%) | 147,059 | 5.50% | 13G (passive) | Dec 24, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of DRMA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 20,203 | 0.50% | $26.06K | −28,131 | 0.00% |
| Welch & Forbes LLC | 20,000 | 0.50% | $25.80K | – | 0.00% |
| State Street Corp | 18,747 | 0.47% | $24.18K | New | 0.00% |
| UBS Group AG | 16,796 | 0.42% | $21.67K | −18,812 | 0.00% |
| Susquehanna International Group, Llp | 15,989 | 0.40% | $20.63K | New | 0.00% |
| XTX Topco Ltd | 14,787 | 0.37% | $19.08K | New | 0.00% |
| Advisory Alpha, LLC | 10,000 | 0.25% | $12.90K | New | 0.00% |
| Tower Research Capital LLC (TRC) | 3,860 | 0.10% | $4.98K | +3,144 | 0.00% |
| MCF Advisors LLC | 1,732 | 0.04% | $2.24K | – | 0.00% |
| Barclays PLC | 270 | 0.01% | $348 | New | 0.00% |
| SBI Securities Co., Ltd. | 101 | 0.00% | $130 | – | 0.00% |
| Highline Wealth Partners LLC | 26 | 0.00% | $34 | New | 0.00% |
| Morgan Stanley | 2 | 0.00% | $3 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 13 | 0M | 3.0% | 7 / 1 | 2 / 1 | 0M | 0M |
| Q1 2026 | 7 | 0M | 2.6% | 3 / 1 | 3 / 22 | 0M | 3M |
| Q4 2025 | 27 | 4M | 94.1% | 10 / 10 | 4 / 3 | 3M | 0M |
| Q3 2025 | 20 | 1M | 29.6% | 3 / 15 | 2 / 10 | 1M | 0M |
| Q2 2025 | 27 | 0M | 10.3% | 10 / 9 | 5 / 4 | 0M | 0M |
| Q1 2025 | 22 | 0M | 8.7% | 4 / 4 | 8 / 8 | 0M | 0M |
| Q4 2024 | 26 | 0M | 8.0% | 8 / 7 | 3 / 8 | 0M | 0M |
| Q3 2024 | 26 | 0M | 2.4% | 5 / 6 | 4 / 6 | 0M | 0M |
| Q2 2024 | 27 | 0M | 2.4% | 9 / 18 | 0 / 5 | 0M | 0M |
| Q1 2024 | 23 | 0M | 0.1% | 8 / 5 | 1 / 10 | 0M | 0M |
| Q4 2023 | 25 | 0M | 0.1% | 12 / 4 | 0 / 2 | 0M | 0M |
| Q3 2023 | 15 | 0M | 0.0% | 2 / 1 | 3 / 4 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
2 funds held DRMA in Q2 2026, 0% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of DRMA | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 41,321 | 1.03% | $53.72K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 1,106 | 0.03% | $1.44K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Gerald T. Proehl | PRESIDENT, CHAIRMAN, CEO, Director, 10% owner | 372,615 | 9.26% | Aug 18, 2026 |
| Hoose Kyri K. Van | SVP, CFO | 232,463 | 5.78% | Aug 18, 2026 |
| Munera Maria E. Bedoya-Toro | SVP, Regulatory Affairs | 1,046 | 0.03% | Mar 17, 2026 |
| Christopher J. Nardo | Senior VP, CDO | 27,560 | 0.69% | Jan 6, 2026 |
| Kathleen D. Scott | Director | 1 | 0.00% | Jun 16, 2026 |
| Mary Fisher | Director | 196,946 | 4.90% | Jan 6, 2026 |
| Andrew Seth Sandler | Director | 24,184 | 0.60% | Jan 6, 2026 |
| David F. Hale | Director | 81,469 | 2.03% | Jan 6, 2026 |
| Steven J. Mento | Director | – | – | Jan 6, 2026 |
| Wendell Wierenga | Director | 62,398 | 1.55% | Jan 6, 2026 |
| Brittany Bradrick | Director | 23,443 | 0.58% | Jan 6, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Hoose Kyri K. Van SVP, CFO | Aug 16, 2026 | Award | +102,040 | – | – | 232,463 |
| Gerald T. Proehl PRESIDENT, CHAIRMAN, CEO, Director, 10% owner | Aug 16, 2026 | Award | +170,068 | – | – | 292,631 |
| Kathleen D. Scott Director | Jun 16, 2026 | Sale | −11 | $1.19 | $13 | 0 |
| Munera Maria E. Bedoya-Toro SVP, Regulatory Affairs | Feb 17, 2026 | Buy | +1,000 | $1.27 | $1.27K | 1,012 |
| Gerald T. Proehl PRESIDENT, CHAIRMAN, CEO, Director, 10% owner | Dec 23, 2025 | Award | +490,196 | – | – | 490,255 |
| Gerald T. Proehl PRESIDENT, CHAIRMAN, CEO, Director, 10% owner | Dec 23, 2025 | Award | +122,549 | – | – | 122,563 |
| Hoose Kyri K. Van SVP, CFO | Dec 23, 2025 | Award | +122,549 | – | – | 130,423 |
| David F. Hale Director | Jan 23, 2025 | Award | +78,741 | – | – | 80,957 |
| Gerald T. Proehl President, CEO and Chairman, Director, 10% owner | Jan 21, 2025 | Award | +787,402 | – | – | 799,508 |
| Hoose Kyri K. Van SVP, CFO | Jan 21, 2025 | Award | +78,741 | – | – | 78,741 |
| Mary Fisher Director | Jan 21, 2025 | Award | +196,851 | – | – | 196,946 |
| Kathleen D. Scott Director | Oct 6, 2022 | Award | +11,359 | – | – | 27,145 |
| Mary Fisher Director | Oct 6, 2022 | Award | +9,810 | – | – | 23,443 |
| Brittany Bradrick Director | Oct 6, 2022 | Award | +9,810 | – | – | 23,443 |
| Andrew Seth Sandler Director | Oct 6, 2022 | Award | +10,120 | – | – | 24,184 |
| David F. Hale Director | Oct 6, 2022 | Award | +30,155 | – | – | 75,720 |
| Wendell Wierenga Director | Oct 6, 2022 | Award | +20,654 | – | – | 62,398 |
| Kathleen D. Scott Director | Jul 7, 2022 | Award | +9,960 | – | – | 15,786 |
| Wendell Wierenga Director | Jul 7, 2022 | Award | +18,110 | – | – | 41,744 |
| Mary Fisher Director | Jul 7, 2022 | Award | +8,602 | – | – | 13,633 |
| Andrew Seth Sandler Director | Jul 7, 2022 | Award | +8,874 | – | – | 14,064 |
| Brittany Bradrick Director | Jul 7, 2022 | Award | +8,602 | – | – | 13,633 |
| David F. Hale Director | Jul 7, 2022 | Award | +26,441 | – | – | 45,565 |
| David F. Hale Director | Apr 7, 2022 | Award | +15,466 | – | – | 19,124 |
| Mary Fisher Director | Apr 7, 2022 | Award | +5,031 | – | – | 5,031 |
| Brittany Bradrick Director | Apr 7, 2022 | Award | +5,031 | – | – | 5,031 |
| Kathleen D. Scott Director | Apr 7, 2022 | Award | +5,826 | – | – | 5,826 |
| Andrew Seth Sandler Director | Apr 7, 2022 | Award | +5,190 | – | – | 5,190 |
| Wendell Wierenga Director | Apr 7, 2022 | Award | +10,593 | – | – | 15,471 |
| Gerald T. Proehl President, CEO and Chairman, Director, 10% owner | Nov 23, 2021 | Buy | +20,000 | $2.40 | $48.00K | 59,512 |
| Investment Ventures LLC Proehl 10% owner | Aug 17, 2021 | Conversion | +181,585 | – | – | 1,572,000 |
| Investment Ventures LLC Proehl 10% owner | Aug 17, 2021 | Conversion | +1,247,904 | – | – | 2,819,904 |
| Investment Ventures LLC Proehl 10% owner | Aug 17, 2021 | Conversion | +85,640 | – | – | 2,905,544 |
| Investment Ventures LLC Proehl 10% owner | Aug 17, 2021 | Conversion | +111,951 | – | – | 1,390,415 |
| Investment Ventures LLC Proehl 10% owner | Aug 17, 2021 | Conversion | +361,147 | – | – | 1,278,464 |
| Wendell Wierenga Director | Aug 17, 2021 | Conversion | +8,163 | – | – | 13,041 |
| Munera Maria E. Bedoya-Toro Senior Vice President | Aug 17, 2021 | Conversion | +13,658 | – | – | 84,143 |
| Munera Maria E. Bedoya-Toro Senior Vice President | Aug 17, 2021 | Conversion | +17,421 | – | – | 70,485 |
| Munera Maria E. Bedoya-Toro Senior Vice President | Aug 17, 2021 | Conversion | +4,878 | – | – | 53,064 |
| Munera Maria E. Bedoya-Toro Senior Vice President | Aug 17, 2021 | Conversion | +19,512 | – | – | 48,186 |
| Munera Maria E. Bedoya-Toro Senior Vice President | Aug 17, 2021 | Conversion | +9,162 | – | – | 28,674 |
| Christopher J. Nardo Senior VP, Development | Aug 17, 2021 | Conversion | +2,439 | – | – | 2,439 |
| David F. Hale Director, 10% owner | Aug 17, 2021 | Conversion | +20,000 | – | – | 331,606 |
| David F. Hale Director, 10% owner | Aug 17, 2021 | Conversion | +27,103 | – | – | 532,925 |
| David F. Hale Director, 10% owner | Aug 17, 2021 | Conversion | +174,216 | – | – | 505,822 |
| David F. Hale Director, 10% owner | Aug 17, 2021 | Buy | +35,714 | – | – | 35,714 |
| David F. Hale Director, 10% owner | Aug 17, 2021 | Conversion | +12,195 | – | – | 311,606 |
| David F. Hale Director, 10% owner | Aug 17, 2021 | Conversion | +44,777 | – | – | 299,411 |
| Thomas Insley Chief Financial Officer | Aug 17, 2021 | Conversion | +4,581 | – | – | 14,337 |
| Gerald T. Proehl President, CEO and Chairman, Director, 10% owner | Aug 17, 2021 | Conversion | +361,147 | – | – | 1,278,464 |
| Gerald T. Proehl President, CEO and Chairman, Director, 10% owner | Aug 17, 2021 | Conversion | +85,640 | – | – | 2,905,544 |
| Gerald T. Proehl President, CEO and Chairman, Director, 10% owner | Aug 17, 2021 | Conversion | +1,247,904 | – | – | 2,819,904 |
| Gerald T. Proehl President, CEO and Chairman, Director, 10% owner | Aug 17, 2021 | Conversion | +181,585 | – | – | 1,572,000 |
| Gerald T. Proehl President, CEO and Chairman, Director, 10% owner | Aug 17, 2021 | Conversion | +111,951 | – | – | 1,390,415 |
| Gerald T. Proehl President, CEO and Chairman, Director, 10% owner | Aug 17, 2021 | Buy | +142,857 | – | – | 152,857 |
| Gerald T. Proehl President, CEO and Chairman, Director, 10% owner | Aug 17, 2021 | Conversion | +35,767 | – | – | 35,767 |
| Gerald T. Proehl President, CEO and Chairman, Director, 10% owner | Aug 17, 2021 | Conversion | +8,928 | – | – | 8,928 |
| Gerald T. Proehl President, CEO and Chairman, Director, 10% owner | Aug 17, 2021 | Conversion | +17,857 | – | – | 17,857 |
| Gerald T. Proehl President, CEO and Chairman, Director, 10% owner | Aug 16, 2021 | Buy | +10,000 | $4.96 | $49.60K | 10,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Dermata Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 6,963 shares on Aug 21, 2026 over the last 90 days.
See a number that looks wrong?